SEC Form 4 · accession 0000904454-15-000504
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jessica Baker Flechtner
Officer — Sr. VP of Research
Period of report
Aug 3, 2015
Accepted (ET)
Aug 5, 2015 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 3, 2015 | M | 2,229 | $2.02 | A | 4,110 | D | |
| Common Stock | Aug 3, 2015 | S | 2,229 | $13.05 | D | 1,881 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.02 | Aug 3, 2015 | M | 2,229 | D | — | Feb 17, 2021 | Common Stock | 2,229 | 5,673 | D |
Explanation of responses
- F1The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The option was granted on 2/17/2011 and the vesting schedule was completed in February 2015.